Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01210404 · ClinicalTrials.gov registry record · Phase 1

Drug Interaction Study Of Filibuvir With Methadone Among Subjects On Chronic Methadone Maintenance

A Phase 1 study of Chronic Hepatitis C, sponsored by Pfizer.

Completed
Registry status
Phase 1
Development phase
12
Enrollment target
2
Study locations

NCT01210404 is a Phase 1 study of Chronic Hepatitis C that has completed, run by Pfizer. The registered enrollment target is 12 participants, below the 213-participant average among 16 other Chronic Hepatitis C trials with a reported enrollment target (94% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01210404, a Phase 1 study of Chronic Hepatitis C, has completed, sponsored by Pfizer.

COMPLETED
Registry status
Phase 1
Development phase
12 participants
Enrollment target
2
Study locations

Study Summary

Filibuvir, a CYP3A4 inhibitor is being developed for the treatment of chronic Hepatitis C infection. Given the likelihood of co administration of filibuvir and methadone, this study will evaluate the effect of filibuvir on the pharmacokinetics of R/S Methadone.

Conditions Studied

Chronic Hepatitis C

Interventions

  • DRUG filibuvir

Study Locations (2)

Kansas

  • Pfizer Investigational Site - Overland Park
  • Pfizer Investigational Site - Overland Park

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2011-02
Est. Completion 2011-06
Phase Phase 1

Sponsor

Pfizer

1,845 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01210404

The ClinicalTrials.gov registry entry for NCT01210404 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 213-participant average among 16 other Chronic Hepatitis C trials with a reported enrollment target (94% lower). The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chronic Hepatitis C appearing as the primary indexed condition, and to 1 intervention - of which filibuvir is the first listed.

NCT01210404 reports 2 study locations spanning 1 distinct geographic area - top geographies include Kansas.

Frequently Asked Questions

What is clinical trial NCT01210404 about?

NCT01210404 is a clinical study titled "Drug Interaction Study Of Filibuvir With Methadone Among Subjects On Chronic Methadone Maintenance". Filibuvir, a CYP3A4 inhibitor is being developed for the treatment of chronic Hepatitis C infection. Given the likelihood of co administration of filibuvir and methadone, this study will evaluate the effect of filibuvir on the pharmacokinetics of R/S Methadone.

What is the current status of trial NCT01210404?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2011-02. Estimated completion is 2011-06.

What conditions does trial NCT01210404 study?

This clinical trial studies the following conditions: Chronic Hepatitis C.

What interventions are being tested in trial NCT01210404?

The interventions under investigation include: filibuvir (DRUG).

Who is sponsoring clinical trial NCT01210404?

This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01210404 being conducted?

This trial has 2 study locations across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Chronic Hepatitis C

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Chronic Hepatitis C

All registered trials for this condition

Kansas

All trials with a study site in Kansas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.